All Type of News
Medytox achieved highest ever since foundation, KRW 28.8 billion sales, on 1st quarter
Medytox recorded the largest performance ever since its foundation on the first quarter of the year.
A biopharmaceutical company, Medytox(CEO Hyun-ho Jung), made an official notice of its tentative performance on th...
Active contacts for M&As between pharmaceutical and biopharmaceutical companies
It was observed mergers and acquisitions between medium and small pharmaceutical companies and biopharmaceutical companies have actively been made.
According to the pharmaceutical industry, large pharmaceutical compa...
Large Japanese distributions decide to invest in Korean wholesalers
The industry has paid sharp attention on Japanese pharmaceutical distribution companies since they are expected to invest in domestic distribution wholesalers.
According to the distribution industry, a well-known Ja...
Contrave fluctuates obesity treatment market led by Belviq
Like the last year’s Belviq, new obesity treatments approved by the FDA are expected to fluctuate the domestic obesity treatment market.
According to the Ministry of Food and Drug Safety on the 2nd, Kwang Dong Pharma...
Biosimilar price set to 80% of the original, accepting contributions to domestic industry
Since the government is reviewing measures to set limits to the domestic industrial development related to raising biosimilar prices to 70% to 80% that the industry request, the industry paying attention to the result...
“It is lawful to return KRW 50,000 to Cialis patients”
When it comes to the marketing method to return cash to patients which received prescriptions of erectile dysfunction treatments, Lilly argued it is lawful.
It announced it get an authoritative interpretation from an...
Pharmaceutical companies to expand businesses into interesting fields
Listed pharmaceutical companies have started to expand their business into various fields, such as the communal dining service, insurance service, stone, and sporting goods fields.
According to the Yakup Shinmoon’s(w...
Extended tax deductions for new drug R&Ds
In order to foster new industries, the government decided to apply tax deduction even for expenses of Phase 3 clinical trials that are conducted in Korea.
Moreover, it also decided to raise the ‘New Industry Fosterin...
Presidential visit to Iran, expected by pharmaceutical industry over expansion and exports
Due to the President Geun-hye Park’s visit to Iran next month, expectations towards pharmaceutical exports have been raised.
There are approximately 40 domestic pharmaceutical companies expanded into Iran, but most ...
“Can the regulation of reevaluation for modified drugs be improved?”
Although the pharmaceutical industry raised a voice towards preferential regulations for global expansion, such as standard relaxation of reevaluation on incrementally modified drugs, it seems it still needs more time...
